Authors
Latest:
Help Patients Obtain HIV MedicationsLearn how retail or specialty pharmacy distribution can affect access to these important drugs.
Latest:
Toxins or Trauma?A look at unintentional causes of injury death in the United States and medication safety.
Latest:
Focus on Smoking Cessation During COVID-19: Review of Varenicline PharmacogenomicsPatients with current or former smoking status may be at an increased risk of severe illness due to COVID-19.
Latest:
Patterns of Specific Testing for Patients With Chronic Myelogenous LeukemiaStudy assessed chemotherapy use in patients with chronic myelogenous leukemia (CML) to determine how use of CML-specific tests impacted drug selection and modification.
Latest:
The Role of PARP Inhibitors in Treating Ovarian CancerRucaparib is FDA approved in patients with a BRCA mutation and who have received 2 more prior lines of previous chemotherapy.
Latest:
Counsel Patients About Self-Care Measures, OTC Treatments for Seasonal AllergiesProper diagnosis and selection of products is crucial to management of hay fever
Latest:
To D or Not to D: That Is the QuestionVitamin D encompasses a group of fatsoluble secosterols that are found in certain foods and supplements and can also be produced when synthesis of vitamin D is triggered after the sun’s ultraviolet rays touch skin.
Latest:
New Technologies Boost Pharmacist's RoleDigital health products and solutions expand ways to guide prevention and treatment.
Latest:
Commentary: Specialty Pharmacy: The Whole PackagePharmacies entering the specialty drug market will need to deliver key elements in order to succeed.
Latest:
Crohn's Disease%u2014Strategies to Improve Quality of LifeCrohn's disease, an inflammatory bowel disease, has no cure; the primary goal of therapy is to improve quality of life by minimizing gastrointestinal and extraintestinal complications of the disease.
Latest:
Patient Engagement and Wellness: A Critical Piece of the Puzzle as Health Care Moves to Value-Based ModelsAlthough we have seen some progress through the proliferation of patient-centered medical homes, most clinicians have not fundamentally altered their basic approach to engaging with their patients.
Latest:
Artificial Intelligence Is Revolutionizing Controlled Substance Diversion DetectionAI is able to quickly analyze, identify, and route data for investigation.
Latest:
Help Patients Shorten the Duration of a ColdA few unexpected products, such as honey, could end the misery more quickly than expected.
Latest:
Pharmacists as Influencers of Patient AdherencePharmacists can make the most of their interactions with patients.
Latest:
Achieving ValueCost is a part of the value proposition, but it needs to be put in place at the system level.
Latest:
Specialty Pharmacy Takes Center Stage in Cancer CareThe oncology pharmaceutical market is rapidly growing and changing.
Latest:
BCG: The Current Treatment of Choice for Bladder CancerMr. Sherman is president of Sherman Consulting Services Inc.
Latest:
Vaccine Billing Coverage Options: Seasonal Influenza and Future COVID-19 VaccinesA thorough understanding of immunization billing processes for Medicare, Medicaid, and other third-party payers will be critical to ensure pharmacy staff can efficiently serve their communities and facilitate a smooth reimbursement process.
Latest:
Treatment of Neuropathic PainChronic pain has been defined by the International Association for the Study of Pain as pain that persists beyond the normal tissue healing time of 3 months, and it may be classified into 3 distinct categories: nociceptive, neuropathic, and a mixture of the two.
Latest:
Impact of Medicare Part D on Utilization and ExpendituresExamination of pharmacy behaviors before and after implementation indicated that restrictions in pharmacy benefits may not deter utilization for Part D.
Latest:
Opportunities and Challenges With Value-Based ContractingGiven the need to provide patients with access to effective medications, it is likely that we will see more value-based contracts in the future; however, some key operational, communications, and regulatory barriers will need to be addressed first.
Latest:
Oncology Overview: Taking a Closer Look at Axicabtagene CiloleucelAxicabtagene ciloleucel (Yescarta) received accelerated FDA approval on March 5, 2021, for the treatment of adult patients with relapsed or refractory FL after 2 or more lines of systemic therapy.
Latest:
All That Is Old Becomes New Again: New Roles for Old, Antiplatelets in STEMIThis article discusses the potential role of tirofiban as a complementary agent to the newer oral P2Y12 receptor blockers in STEMI patients.
Latest:
The Impact of COVID-19 on Recent Pharmacy School GraduatesPharmacy students, particularly the graduating class of 2020, have been uniquely affected by the coronavirus disease 2019 (COVID-19) pandemic.
Latest:
Vaccinations in the Emergency Department: Current and Emerging Practices to Boost Public HealthPiloting new emergency department-based vaccination campaigns and fine-tuning existing programs may reduce morbidity and mortality associated with vaccine-preventable diseases.
